Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Miguel Filipe Tavares Da Luz Soares

    Autor

  • Hélder Novais E Bastos

    Autor

  • Antonio Manuel Martins De Morais

    Autor

Participantes de fora da FMUP

  • Mota, PC
  • Vasconcelos, CD
  • Ferreira, AC
  • Lima, BA
  • Manduchi, E
  • Moore, JH
  • Melo, N
  • Pereira, JM
  • Guimaraes, S
  • Moura, CS
  • Marques, JA

Unidades de investigação

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown etiology. The role of genetic risk factors has been the focus of numerous studies probing for associations of genetic variants with IPF. We aimed to determine whether single-nucleotide polymorphisms (SNPs) of four candidate genes are associated with IPF susceptibility and survival in a Portuguese population. A retrospective case-control study was performed with 64 IPF patients and 74 healthy controls. Ten single-nucleotide variants residing in the MUC5B, TOLLIP, SERPINB1, and PLAU genes were analyzed. Single- and multi-locus analyses were performed to investigate the predictive potential of specific variants in IPF susceptibility and survival. Multifactor dimensionality reduction (MDR) was employed to uncover predictive multi-locus interactions underlying IPF susceptibility. The MUC5B rs35705950 SNP was significantly associated with IPF: T allele carriers were significantly more frequent among IPF patients (75.0% vs 20.3%, P < 1.0 x 10(-6)). Genotypic and allelic distributions of TOLLIP, PLAU, and SERPINB1 SNPs did not differ significantly between groups. However, the MUC5B-TOLLIP T-C-T-C haplotype, defined by the rs35705950-rs111521887-rs5743894-rs5743854 block, emerged as an independent protective factor in IPF survival (HR = 0.37, 95% CI 0.17-0.78, P = 0.009, after adjustment for FVC). No significant multi-locus interactions correlating with disease susceptibility were detected. MUC5B rs35705950 was linked to an increased risk for IPF, as reported for other populations, but not to disease survival. A haplotype incorporating SNPs of the MUC5B-TOLLIP locus at 11p15.5 seems to predict better survival and could prove useful for prognostic purposes and IPF patient stratification. Key messages The MUC5B rs35705950 minor allele is associated with IPF risk in the Portuguese. No predictive multi-locus interactions of IPF susceptibility were identified by MDR. A haplotype defined by MUC5B and TOLLIP SNPs is a protective factor in IPF survival. The haplotype may be used as a prognostic tool for IPF patient stratification.

Dados da publicação

ISSN/ISSNe:
0946-2716, 1432-1440

JOURNAL OF MOLECULAR MEDICINE-JMM  Springer Verlag

Tipo:
Article
Páginas:
1341-1353
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 3

Citações Recebidas na Scopus: 7

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Idiopathic pulmonary fibrosis; TOLLIP; MUC5B promoter; Haplotypes; IPF survival; Common genetic variants

Financiamento

Proyectos asociados

Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG) -NCT05635032

Investigador Principal: Hélder Novais e Bastos

Estudo Observacional Académico (FIBRALUNG) . FCT . 2021

Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2020

Impact of Chronic Obstructive Pulmonary Disease in surgical outcomes of lung cancer patients undergoing curative intent surgery

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2021

Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2021

Non-invasive assessment of Benign Tracheal Stenosis.

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação